http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103588732-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89c1bc172eec1b45d7ca20e4012eeafd |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D303-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D303-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5de849dcedecf3db2e55e4ce2b38eb80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f6bd77dff43141c3d5c99e83171464f |
| publicationDate | 2015-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103588732-B |
| titleOfInvention | Salicylamide derivative crystal |
| abstract | The invention discloses a salicylamide derivative crystal and specifically discloses a compound shown in the formula 1. Under Cu-K alpha radiation, in the powder x-ray diffraction pattern represented by 2 theta angle, the compound has a diffraction peak at about 9.4 degrees. The invention also discloses a preparation method of the compound shown in the formula 1, a pharmaceutical composition containing the compound, and a use of the compound or its pharmaceutically acceptable salts, solvates, esters, prodrugs and isomers in preparation of drugs for treating or preventing cancers, inflammation, autoimmune disease, diabetes, diabetic complication, infection, cardiovascular diseases and ischemia-reperfusion injuries. The compound shown in the formula 1 has good drug properties. |
| priorityDate | 2013-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.